Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits

Bertoni, E.; Rosati, Alberto; Zanazzi, M.; Moscarelli, L.; Maria, L. Di; Piperno, R.; Orsi, A; Parri, F.; Dedola, G; Salvadori, Maurizio

doi:10.1016/s0041-1345(98)00549-1

Transplantation Proceedings

1998

DOI: 10.1016/s0041-1345(98)00549-1

|View full text |Cite

Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits

E. Bertoni

Alberto Rosati

M. Zanazzi

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2000

2006

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These include acyclovir and valacyclovir [8,9], but ganciclovir and, more recently, val- ganciclovir have more in vitro activity and clinical efficacy and are more appropriate for CMV prevention and treatment [10].…”

mentioning

confidence: 99%

Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies

Small¹,

Lau²,

Snydman³

2006

CLIN INFECT DIS

141

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies

Small¹,

Lau²,

Snydman³

2006

CLIN INFECT DIS

141

View full text Add to dashboard Cite

show abstract

Current Management Strategies for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients

Abu-Nader

Patel

2000

BioDrugs

View full text Add to dashboard Cite

Cytomegalovirus (CMV) infection in solid organ transplantation is associated with significant morbidity and mortality. Primary infection, secondary infection or superinfection may occur in this setting. Progression to disease may ensue with development of symptoms, with or without organ involvement. The mainstay of treatment of CMV disease is intravenous ganciclovir. Aside from protective organ matching and use of CMV-seronegative blood products, methods of preventing CMV infection and disease include passive immunisation with immunoglobulins, vaccination, and prophylaxis with antiviral agents such as aciclovir, oral or intravenous ganciclovir, and oral valaciclovir. A promising subunit vaccine is currently being investigated. Pre-emptive therapy is a form of prevention that is based either on the early detection of CMV or targeting of transplant recipients with risk factors for CMV. New sensitive laboratory assays, including the pp65 antigenaemia assay, qualitative, quantitative and reverse-transcription polymerase chain reaction assays, hybridisation assays, and nucleic acid sequence-based assays, have the ability to detect early CMV replication before disease becomes evident. These assays are being used as prospective surveillance tests, with pre-emptive therapy initiated when they become positive or demonstrate an increasing titre.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits

Cited by 2 publications

References 4 publications

Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies

Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies

Current Management Strategies for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients

Contact Info

Product

Resources

About